4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-032108
Director sold 94,906 shares at $8.02 ($761,146)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Gautam Director | 2025-06-16 | Sale 10b5-1 | −94,906 | $8.02 | $761,146 | 1,609,144 | D |
| Open-market sales · 94,906 sh · avg $8.02 · $761,146 | |||||||
Loading xslF345X05/wk-form4_1750277496.xml…